Our Paradigm PCDx test is a broad panel to help guide late-stage cancer patients to the appropriate therapy. We plan to expand the launch of the tissue-based Paradigm PCDx test through our Precision Oncology team later this year. Followed by a full-year roll out next year, we believe this Oncology sales team is one of the best in diagnostics. We're also working to enhance the tissue-based test and introduce a blood-based version of the Paradigm test. Will provide more precise smarter answers across the cancer continuum with Cologuard, Oncotype DX, and Paradigm PCDx.